Chemical

1
Chemical Biological Defense Program Science
Technology

• COL Ben Hagar
• Deputy, Joint Science Technology Office for CB
  Defense
• Defense Threat Reduction Agency

2
Overview

• Continued strong Department and Congressional
  support for CBDP ST
• Strengthened ability to transition from DARPA
  programs
• DTRA re-aligning its RD efforts
• STRATCOM Combating WMD role

3
Preserving warfighter effectiveness through
medical countermeasures
Diagnostics
Pretreatments/ Prophylaxes
Therapeutics
Emerging Threats/ Special Programs
4
Preserving warfighter effectiveness with advanced
equipment and materials
5
Principle Plain Language Thrusts

• Earliest Warning
• Detection
• Medical Surveillance
• Information Dissemination
• Broad Spectrum Medical Countermeasures
• Pretreatment
• Therapeutics
• How Clean is Safe?
• Decontamination
• Low-Level Toxicology
• Environmental Fate of Agent

6
Medical CB ST Strategy

• Place greater emphasis on developing medical
  countermeasures effective against a broader range
  of pathogens to mitigate novel agent effects
• Accelerate development cycle (rapid vaccine and
  drug development)
• Exploit cutting edge technologies to improve
  medical countermeasures against established
  high-priority CB agents and against emerging CB
  agents and effects
• Leverage existing capability found in other
  federal agencies, industry, and international
  partners
• Sustain long-term investment in developing
  candidates for capability gaps
• Ensure knowledge base to support future
  technology development

7
Physical ST program strategy

• Balance between requirements pull
• Align with the JRO to address capability needs
• Align with JPEO programs to address technology
  gaps
• Answer critical science questions that support
  policy, doctrine and requirements decisions
• and technology push
• Centralize investment in basic research (6.1)
• Identify and exploit technology opportunities
• Identify and respond to new and emerging threats
• Transition new and innovative technologies with
  JPEO
• Maintain a robust technology base knowledge,
  research capabilities, and test and evaluation
  methodologies

8
How we have changed the Physical ST business
strategy

• Find and Fund the Best Performers
• Maintain an active outreach to a broad base of
  potential performers in government, academia, and
  industry
• Emphasize teaming and comprehensive approaches
• Allow the best ideas to emerge through
  competition
• Select the best science and most innovative
  ideas no favorites, no quotas
• Exploit Cutting Edge Technologies
• Find and fund new cross-cutting technologies
• Leverage new ideas from other sources
• Sustain Long-Term Investment
• Fund promising technologies from concept through
  transition

9
and developed an overarching science strategy

• Build a Fundamental Understanding of CB Agents
• Physical and chemical properties
• Fundamental interactions with other materials and
  environment
• Pathological and toxicological properties
• Exploitable signatures
• Leverage Advancements in Strategic Research
• Develop Revolutionary Solutions
• Integrated system for complete knowledge of the
  CB environment
• Unencumbering full protection
• Rapid inactivation of CB hazards

• Information dominance
• Nanoscience
• Bioengineering sciences

• Multifunctional materials
• Human performance science

10
FY06 Core Funding Increases
11
Scientific Challenges

• Develop a fundamental understanding of properties
  and mechanisms underlying EM detection of CB
  agents in order to better identify and predict
  unique and distinguishable signatures
• Formulate optimal filters for fusion of disparate
  sensor information in non-linear dynamic networks
• Discover new materials that are sorbent and/or
  stably reactive which provide order-of-magnitude
  CB agent removal rates and capacity over current
  activated carbon technologies
• Develop a fundamental understanding of CB agent
  and decontaminant transport in solid substrates
  to predict agent fate, removal efficacy (or
  neutralization), and material effects